BELCANZI

Serial Number 79284173
Registration 6443402
700

Registration Progress

Application Filed
Mar 30, 2020
Under Examination
Approved for Publication
May 25, 2021
Published for Opposition
May 25, 2021
Registered
Aug 10, 2021

Trademark Image

BELCANZI

Basic Information

Serial Number
79284173
Registration Number
6443402
Filing Date
March 30, 2020
Registration Date
August 10, 2021
Published for Opposition
May 25, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 10, 2021
Registration
Registered
Classes
005

Rights Holder

Fresenius Kabi Deutschland GmbH

27
Address
Else-Kroener-Str. 1
61352 Bad Homburg
DE

Ownership History

Fresenius Kabi Deutschland GmbH

Original Applicant
27
DE

Fresenius Kabi Deutschland GmbH

Owner at Publication
27
DE

Fresenius Kabi Deutschland GmbH

Original Registrant
27
DE

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
650 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-08-10)
Due Date
August 10, 2027
Grace Period Ends
February 10, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
May 24, 2023 RNWL P INTERNATIONAL REGISTRATION RENEWED Loading...
Feb 20, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jan 13, 2022 XXCR P GENERIC MADRID TRANSACTION CREATED Loading...
Jan 13, 2022 XXSS O GENERIC MADRID TRANSACTION SENT TO IB Loading...
Nov 10, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Aug 10, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 30, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
May 25, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 25, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 5, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 5, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
May 5, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Apr 15, 2021 ALIE A ASSIGNED TO LIE Loading...
Apr 15, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 15, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 15, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 11, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 25, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 28, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 28, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 20, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jun 19, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 18, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
May 1, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 27, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 23, 2020 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical products for human use, namely, products for the treatment of diseases and disorders of the immune system, inflammatory diseases and disorders, oncological diseases and disorders and viral infections
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "BELCANZI" has no meaning in a foreign language.

Classification

International Classes
005